Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice

Akhtar, 2005, Antimicrobial peptide 99mTc-Ubiquicidin 29–41 as human infection-imaging agent: clinical trial, J Nucl Med, 46, 567 Alvarez-Bravo, 1994, Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus, J Biochem, 302, 535, 10.1042/bj3020535 Alvarez-Bravo, 1995, Mode of action of an antibacterial peptide, KLKLLLLLKLK-NH2, J Biochem, 117, 1312, 10.1093/oxfordjournals.jbchem.a124860 Bellamy, 1992, Identification of the bactericidal domain of lactoferrin, Biochim Biophys Acta, 1121, 130, 10.1016/0167-4838(92)90346-F Braunstein, 2004, In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria, Antimicrob Agents Chemother, 48, 3127, 10.1128/AAC.48.8.3127-3129.2004 Chou, 1974, Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins, Biochemistry, 13, 211, 10.1021/bi00699a001 de Koster, 1995, The use of dedicated peptide libraries permits the discovery of high affinity binding peptides, J Immunol Methods, 187, 179, 10.1016/0022-1759(95)00182-A Ganz, 1999, Antibiotic peptides from higher eukaryotes: biology and applications, Mol Med Today, 5, 292, 10.1016/S1357-4310(99)01490-2 Garnier, 1978, Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins, J Mol Biol, 120, 97, 10.1016/0022-2836(78)90297-8 Hancock, 2002, Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics, Curr Drug Targets Infect Disord, 2, 79, 10.2174/1568005024605855 Hiemstra, 1999, Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages, J Leukocyte Biol, 66, 423, 10.1002/jlb.66.3.423 Lupetti, 2003, Radiopharmaceuticals: new antimicrobial agents, Trends Biotechnol, 21, 70, 10.1016/S0167-7799(02)00032-X Melendez-Alafort, 2005, Biokinetics of 99mTc-UBI 29–41 in humans, Nucl Med Biol, 31, 373, 10.1016/j.nucmedbio.2003.10.005 Nibbering, 2004, Technetium-99m labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with (multidrug resistant) Staphylococcus aureus, J Nucl Med, 45, 321 Tollin, 2003, Antimicrobial peptides in the first line defence of human colon mucosa, Peptides, 24, 523, 10.1016/S0196-9781(03)00114-1 Welling, 1998, Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation, J Clin Invest, 102, 1583, 10.1172/JCI3664 Welling, 2002, Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections, Nucl Med Biol, 29, 413, 10.1016/S0969-8051(02)00292-5 Welling, 2000, Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations, Eur J Nucl Med, 27, 292, 10.1007/s002590050036 Zijlstra, 2006, Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet, Appl Radiat Isotop, 64, 802, 10.1016/j.apradiso.2006.02.095